Political disruption risks loss of access to comparator drug

Political disruption threatened to cut off access to a critical comparator drug—putting a global clinical program at risk.

This case study explores how Almac Clinical Services swiftly navigated geopolitical instability, supply‑chain uncertainty, and regulatory pressures to secure uninterrupted access to essential materials. Through proactive risk assessment, strategic sourcing, and agile operational planning, Almac protected study timelines and safeguarded data integrity, demonstrating the value of resilient clinical supply management in an unpredictable world.